Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales

  title={Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales},
  author={C{\^o}me Lepage and Bernard Rachet and Val{\'e}rie Jooste and Jean Faivre and Michel Philippe Coleman},
  journal={The American Journal of Gastroenterology},
BACKGROUND AND AIMS: Substantial changes have occurred in the epidemiology of esophageal adenocarcinoma. We examined trends in incidence in a large national population.METHODS: All esophageal adenocarcinomas registered in England and Wales over a 31-year period (1971–2001) were included. Incidence rates were calculated by age, sex, and socio-economic category, by 5-year period, and by birth cohort.RESULTS: A total of 43,753 esophageal adenocarcinomas were analyzed. Age-standardized (world… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 111 extracted citations

Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma.

Therapeutic advances in gastroenterology • 2015
View 7 Excerpts
Highly Influenced


Publications referenced by this paper.
Showing 1-10 of 35 references

Cancer of the lung

M Spitz, X Wu, A Wilkinson
View 1 Excerpt

Esophageal cancer

W Blot, J McLaughlin, J. Fraumeni
Cancer epidemiology and prevention, • 2006
View 3 Excerpts

Population attribuable risks of oesophageal and gastric cancers

LS Engel, WH Chow, TL Vaughan
J Natl Cancer Inst 2003;95:1404–13 • 2003

Similar Papers

Loading similar papers…